Litcius/Paper detail

Recent advances in the development of dual ALK/ROS1 inhibitors for non-small cell lung cancer therapy

Yingxue Li, Yanna Lv, Cheng Zhang, Binyu Fu, Yue Liu, Jinxing Hu

2023European Journal of Medicinal Chemistry11 citationsDOIOpen Access PDF

Topics & Concepts

ROS1Cancer researchLung cancerKinaseTargeted therapyAnaplastic lymphoma kinaseChemistryCancerDrug discoveryAdenocarcinomaMedicineInternal medicineBiochemistryMalignant pleural effusionLung Cancer Treatments and MutationsLung Cancer Research StudiesCancer therapeutics and mechanisms
Recent advances in the development of dual ALK/ROS1 inhibitors for non-small cell lung cancer therapy | Litcius